Public Alert No. 11/2025 – Recall of Various Products by Sun Pharma, Glenmark, and Zydus Pharmaceuticals Over Manufacturing Issues
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public of the recall of various products by three drug manufacturing companies in the United States. According to recent information by the U.S. Food and Drug Administration (FDA), leading pharmaceutical firms in India, Glenmark Pharmaceuticals, Sun Pharmaceutical Industries, and Zydus, are recalling multiple drug products […]
Public Alert No. 010/2025 – Alert on the Sale of a Fake Product Named Wonder Calcium by Health and Hygiene
The National Agency for Food and Drug Administration and Control (NAFDAC) is informing healthcare providers and the public about a report of the sale of a falsified product- Wonder Calcium with fake NAFDAC Registration Number 04-1029. NAFDAC received a complaint from Asad Pharmaceutical Ltd, reporting on the sale of a falsified product (Wonder Calcium). The […]
Public Alert No. 09/2025 – Voluntary Recall of Zovirax IV Infusion by GlaxoSmithKline (GSK) Limited Due to Potential Quality Defects
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public that GlaxoSmithKline (GSK) Limited has voluntarily recalled one lot of Zovirax IV Infusion 250mg RN3T in Hong Kong due to potential quality defects. The Department of Health (DH) Hong Kong received notification from GSK that its branch in Taiwan is […]
Press Briefing on the Regulatory Framework for Bioequivalence and it’s Relevance to the Nigerian Market
Bioequivalence (BE) is a critical scientific concept that ensures the quality, safety, and efficacy of generic drug products in comparison to their innovator counterparts. It establishes the interchangeability of generic medicines with their branded equivalents, relying on statistically significant clinical outcomes to confirm that generics deliver comparable therapeutic effects. Innovator drugs undergo rigorous phases of […]
Public Alert No. 08/2025 –Alert on the Presence of Counterfeit Artemether/Lumefantrine Tablets Circulating Under Brand Name Aflotin 20/120 in Nigeria
The National Agency for Food and Drug Administration and Control is notifying the public of the presence of one batch of counterfeit Artemether/Lumefantrine tablets circulating under the brand name Aflotin 20/120 in Nigeria. The counterfeit product was discovered and reported to the Agency by the genuine manufacturer, Ajanta Pharma Limited Mumbai, India, According to Ajanta […]
Public Alert No. 07/2025 – Alert on Falsified OXYCONTIN 80mg identified in the WHO European Region
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public of one batch of falsified OXYCONTIN 80mg (oxycodone hydrochloride) detected in the unregulated market in Switzerland. This was reported to the World Health Organization (WHO) by the genuine manufacturer, MUNDIPHARMA, in February 2025. The falsified product imitates the genuine OXYCONTIN […]
Investigation Report of Scamming of Foreign Companies Using Fake NAFDAC Documents by Mr. Ikoro Mang Ifendua: A Case of Fraud and Obtaining Funds by Impersonation as an Official of NAFDAC
Mr. Ikoro Mang Ifendu of 26, Park Road, Aba Abia State, born on the 2nd of January, 1973, was arrested on the 7th of February 2025 at Ogborn Hills, Aba, Abia State in a case of alleged fraud and obtaining huge funds by false pretence from unsuspecting foreigners that cuts across various countries as a […]
Public Alert No. 06/2025 – Alert on the Sale of Counterfeit Noristerat Injection 200mg in Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the sale of Chlorpheniramine and Dexamethasone injection ampoules that are mislabelled and repacked as Noristerat Injection 200mg. Samples of the counterfeit product have been reported to be found in Niger State, Bauchi State, and especially the Coordinated Wholesale Centre […]
Public Alert No. 05/2025 – Alert on the Circulation of Falsified Cikatem (Artemether 180mg/Lumefantrine 1080mg) with Falsified NAFDAC Registration Number NRN A11-100025
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public about the circulation of a confirmed falsified Cikatem (Artemether 180mg/Lumefantrine 1080mg) suspension. This product was discovered in the Coordinated Wholesale Centre (CWC) in Kano following a consumer complaint received and investigated by the post marketing surveillance (PMS) officers of the […]
Blacklisting of Aveo Pharmaceuticals and Banning of Tapentadol and Carisoprodol Combination – Tafrodol or Royal 225
A company named Aveo Pharmaceuticals, based in the outskirts of Mumbai, managed by Vinod Sharma is involved in the production, sale and exportation of a range of addiction pills containing a harmful mix of Tapentadol (a powerful opioid), and Carisoprodol, a banned muscle relaxant with addictive properties that can cause overdose, or death. The mix […]
